{"id":1252,"date":"2020-05-28T01:09:30","date_gmt":"2020-05-28T01:09:30","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1252"},"modified":"2023-08-29T18:02:04","modified_gmt":"2023-08-29T18:02:04","slug":"mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1252","title":{"rendered":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil"},"content":{"rendered":"<p>\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=MSB&amp;lang=cn\">Mesoblast (ASX: MSB)<\/a>\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002<\/p>\n<p>Mesoblast\u8868\u793a\uff0c\u5176\u6536\u5165\u589e\u957f\u4e86113%\uff0c\u8fbe\u52303150\u4e07\u7f8e\u5143\u3002\u8be5\u516c\u53f8\u79f0\uff0c\u6218\u7565\u5408\u4f5c\u4f19\u4f34\u7684\u91cc\u7a0b\u7891\u5f0f\u6536\u5165\u589e\u957f\u4e86127%\uff0c\u8fd9\u662f\u4e1a\u7ee9\u663e\u8457\u6539\u5584\u80cc\u540e\u7684\u4e3b\u8981\u8b66\u544a\u3002<\/p>\n<p>\u6b64\u5916\uff0cMesoblast\u5728\u8fc7\u53bb9\u4e2a\u6708\u91cc\u5c06\u7a0e\u540e\u4e8f\u635f\u51cf\u5c11\u4e8634%\uff0c\u81f34,530\u4e07\u7f8e\u5143\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u62a5\u544a\u79f0\uff0c\u622a\u81f32020\u5e74\u7b2c\u4e00\u5b63\u5ea6\u672b\uff0c\u5176\u624b\u5934\u6709\u8d85\u8fc76000\u4e07\u7f8e\u5143\u7684\u73b0\u91d1\uff0c\u6700\u8fd1\u51e0\u4e2a\u6708\u6210\u529f\u7b79\u96c6\u4e869000\u4e07\u7f8e\u5143\u7684\u8d44\u91d1\u3002<\/p>\n<p>\u9884\u8ba1\u65b0\u8d44\u672c\u5c06\u7528\u4e8e\u5728\u7f8e\u56fd\u4e0a\u5e02\u7684\u5148\u5bfc\u836f\u7269Ryoncil\uff0c\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(GvHD)\uff0c\u6269\u5927\u751f\u4ea7\u89c4\u6a21\u5e76\u7ee7\u7eed\u5176\u4e34\u5e8a\u9879\u76ee\u3002<\/p>\n<p>\u968f\u7740\u8d22\u52a1\u72b6\u51b5\u7684\u6539\u5584\uff0cMesoblast\u8868\u793a\uff0c\u76ee\u524d\u6b63\u96c6\u4e2d\u7cbe\u529b\u7814\u53d1\u5176\u4e3b\u8981\u836f\u7269remestemcel-L\uff0c\u5176\u836f\u7269\u5728\u4eca\u5e74\u5269\u4f59\u65f6\u95f4\u4ee5Ryoncil\u7684\u540d\u5b57\u66f4\u4e3a\u4eba\u719f\u77e5\u3002<\/p>\n<p>\u201c\u6211\u4eec\u7684\u751f\u7269\u5236\u5242\u8bb8\u53ef\u8bc1\u7533\u8bf7\u8425\u9500\u6279\u51c6Ryoncil\u7528\u4e8e\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u7684\u5b69\u5b50\u88abFDA\u76ee\u524d\u4f18\u5148\u5ba1\u67e5,\u6211\u4eec\u5e0c\u671b\u80fd\u591f\u8ba9\u8fd9\u79cd\u5371\u53ca\u751f\u547d\u7684\u4ea7\u54c1\u63d0\u4f9b\u7ed9\u60a3\u8005\u708e\u75c7\u6761\u4ef6\u57282020\u5e74\u671f\u95f4,Mesoblast\u9996\u5e2d\u6267\u884c\u5b98Silviu Itescu\u535a\u58eb\u8bf4\u3002<\/p>\n<p>FDA\u8bbe\u5b9a\u4e86\u201c\u5904\u65b9\u836f\u4f7f\u7528\u8d39\u6cd5\u6848(PDUFA)\u201d\u7684\u884c\u52a8\u65e5\u671f\u4e3a2020\u5e749\u670830\u65e5\uff0c\u5982\u679c\u83b7\u5f97\u6279\u51c6\uff0cMesoblast\u5c06\u7acb\u5373\u5728\u7f8e\u56fd\u53d1\u5e03Ryoncil\u3002<\/p>\n<p>\u5728\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u60a3\u8005\u7684\u8fc7\u7a0b\u4e2d\uff0c\u6f5c\u5728\u7684Ryoncil\u7684\u4f7f\u7528\u4e5f\u53ef\u80fd\u8fdb\u4e00\u6b65\u4fc3\u8fdb\u624b\u672f\u7684\u8fdb\u5c55\u3002<\/p>\n<p>\u76ee\u524d\uff0c\u8be5\u836f\u6b63\u5728\u7f8e\u56fd\u8fdb\u884c3\u671f\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\uff0c\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u5728\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u60a3\u8005\u4e2d\uff0c\u6709\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u7684\u60a3\u8005\u4f7f\u7528\u7684\u662fremestemcel-L\u3002<\/p>\n<p>Mesoblast\u62a5\u9053\uff0c\u5f53\u5176\u836f\u7269\u88ab\u7ed9\u4e8812\u540d\u4f53\u6064\u4f7f\u7528\u7684\u60a3\u8005\u65f6\uff0c75%\u7684\u547c\u5438\u673a\u4f9d\u8d56\u60a3\u8005\u572810\u5929\u5185\u5373\u53ef\u8131\u79bb\u547c\u5438\u673a\u51fa\u9662\u3002<\/p>\n<p>\u5728\u8fc7\u53bb\u76849\u4e2a\u6708\u91cc\uff0cMesoblast\u57fa\u4e8eSR-aGVHD\u4e2dremestemcel-L\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u6570\u636e\uff0c\u63d0\u4ea4\u4e86\u4e00\u4efd\u4f7f\u7528remestemcel-L\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u5f15\u8d77\u7684ARDS\u7684\u8bd5\u9a8c\u6027\u65b0\u836f(IND)\u7533\u8bf7\uff0c\u5e76\u83b7\u5f97FDA\u6279\u51c6\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8868\u793a\uff0c\u76ee\u524d\uff0c\u4e00\u9879\u9488\u5bf9\u7f8e\u56fd30\u4e2a\u5730\u533a\u7684300\u540d\u51a0\u72b6\u75c5\u6bd2\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u60a3\u8005\u76843\u671f\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\u6b63\u5728\u8fdb\u884c\u4e2d\uff0c\u201c\u8ba1\u5212\u4e2d\u7684\u4e2d\u671f\u5206\u6790\u53ef\u80fd\u4f1a\u5bfc\u81f4\u8bd5\u9a8c\u56e0\u6709\u6548\u6027\u6216\u65e0\u6548\u800c\u63d0\u524d\u7ec8\u6b62\u201d\u3002<\/p>\n<h2>\u91cc\u7a0b\u7891\u76ee\u6807<\/h2>\n<p>\u5728\u5c55\u671b\u672a\u676512\u4e2a\u6708\u7684\u76ee\u6807\u65b9\u9762\uff0cMesoblast\u8868\u793a\uff0c\u5c3d\u7ba1\u51a0\u72b6\u75c5\u6bd2\u75c5\u5bf9\u5168\u7403\u7ecf\u6d4e\u7684\u5404\u4e2a\u9886\u57df\u90fd\u9020\u6210\u4e86\u5f71\u54cd\uff0c\u4f46\u5b83\u6253\u7b97\u57282020\u5e74\u5e95\u4e4b\u524d\u5728\u7f8e\u56fd\u63a8\u51faRyoncil\u3002<\/p>\n<p>\u5176\u4ed6\u91cc\u7a0b\u7891\u76ee\u6807\u5305\u62ec\u5b8c\u6210Ryoncil\u6cbb\u7597ARDS\u548cRevascor\u6cbb\u7597\u665a\u671f\u548c\u665a\u671f\u5fc3\u529b\u8870\u7aed\u76843\u671f\u8bd5\u9a8c\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u53e6\u4e00\u9879\u9488\u5bf9\u9000\u53d8\u6027\u690e\u95f4\u76d8\u75be\u75c5\u5f15\u8d77\u7684\u6162\u6027\u4e0b\u8170\u75db\u7684MPC-06-ID\u76843\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6b63\u5728\u8fdb\u884c\u4e2d\u3002<\/p>\n<p>Mesoblast\u8868\u793a\uff0c\u6240\u6709\u60a3\u8005\u7684\u6700\u7ec8\u7814\u7a76\u8bbf\u95ee\u5df2\u7ecf\u5b8c\u6210\uff0c\u6240\u6709\u6570\u636e\u7684\u6301\u7eed\u8d28\u91cf\u5ba1\u67e5\u4e5f\u6b63\u5728\u76f8\u5173\u7814\u7a76\u5730\u70b9\u5b8c\u6210\uff0c\u201c\u6570\u636e\u8bfb\u51fa\u8ba1\u5212\u57282020\u5e74\u4e2d\u671f\u201d\uff0c\u8be5\u516c\u53f8\u8868\u793a\u3002<\/p>\n<p>\u672c\u5468\u65e9\u4e9b\u65f6\u5019,Mesoblast\u544a\u8bc9\u5e02\u573a,\u4e34\u5e8a\u7ed3\u679c\u7684\u540c\u79cd\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSC)\u533b\u5b66\u5728\u513f\u7ae5\u548c\u6210\u4eba\u5728\u4e09\u4e2a\u540c\u884c\u8bc4\u8bae\u7684\u6587\u7ae0\u548c\u793e\u8bba\u53d1\u8868\u5728\u751f\u7269\u5b66\u7684\u53ef\u80fd\u95ee\u9898\u7684\u8840\u6db2\u548c\u9aa8\u9ad3\u79fb\u690d,\u7f8e\u56fd\u79fb\u690d\u5b66\u4f1a\u7684\u5b98\u65b9\u51fa\u7248\u7269\u548c\u7ec6\u80de\u7597\u6cd5\u3002<\/p>\n<p>\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0cMesoblast\u80a1\u4ef7\u4e0a\u6da8\u8fd14%\uff0c\u81f33.98\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002 Mesoblast\u8868\u793a\uff0c\u5176\u6536\u5165\u589e\u957f\u4e86113%\uff0c\u8fbe\u52303150\u4e07\u7f8e\u5143\u3002\u8be5\u516c\u53f8\u79f0\uff0c\u6218\u7565\u5408\u4f5c\u4f19\u4f34\u7684\u91cc\u7a0b\u7891\u5f0f\u6536\u5165\u589e\u957f\u4e86127%\uff0c\u8fd9\u662f\u4e1a\u7ee9\u663e\u8457\u6539\u5584\u80cc\u540e\u7684\u4e3b\u8981\u8b66\u544a\u3002 \u6b64\u5916\uff0cMesoblast\u5728\u8fc7\u53bb9\u4e2a\u6708\u91cc\u5c06\u7a0e\u540e\u4e8f\u635f\u51cf\u5c11\u4e8634%\uff0c\u81f34,530\u4e07\u7f8e\u5143\u3002 \u8be5\u516c\u53f8\u62a5\u544a\u79f0\uff0c\u622a\u81f32020\u5e74\u7b2c\u4e00\u5b63\u5ea6\u672b\uff0c\u5176\u624b\u5934\u6709\u8d85\u8fc76000\u4e07\u7f8e\u5143\u7684\u73b0\u91d1\uff0c\u6700\u8fd1\u51e0\u4e2a\u6708\u6210\u529f\u7b79\u96c6\u4e869000\u4e07\u7f8e\u5143\u7684\u8d44\u91d1\u3002 \u9884\u8ba1\u65b0\u8d44\u672c\u5c06\u7528\u4e8e\u5728\u7f8e\u56fd\u4e0a\u5e02\u7684\u5148\u5bfc\u836f\u7269Ryoncil\uff0c\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(GvHD)\uff0c\u6269\u5927\u751f\u4ea7\u89c4\u6a21\u5e76\u7ee7\u7eed\u5176\u4e34\u5e8a\u9879\u76ee\u3002 \u968f\u7740\u8d22\u52a1\u72b6\u51b5\u7684\u6539\u5584\uff0cMesoblast\u8868\u793a\uff0c\u76ee\u524d\u6b63\u96c6\u4e2d\u7cbe\u529b\u7814\u53d1\u5176\u4e3b\u8981\u836f\u7269remestemcel-L\uff0c\u5176\u836f\u7269\u5728\u4eca\u5e74\u5269\u4f59\u65f6\u95f4\u4ee5Ryoncil\u7684\u540d\u5b57\u66f4\u4e3a\u4eba\u719f\u77e5\u3002 \u201c\u6211\u4eec\u7684\u751f\u7269\u5236\u5242\u8bb8\u53ef\u8bc1\u7533\u8bf7\u8425\u9500\u6279\u51c6Ryoncil\u7528\u4e8e\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u7684\u5b69\u5b50\u88abFDA\u76ee\u524d\u4f18\u5148\u5ba1\u67e5,\u6211\u4eec\u5e0c\u671b\u80fd\u591f\u8ba9\u8fd9\u79cd\u5371\u53ca\u751f\u547d\u7684\u4ea7\u54c1\u63d0\u4f9b\u7ed9\u60a3\u8005\u708e\u75c7\u6761\u4ef6\u57282020\u5e74\u671f\u95f4,Mesoblast\u9996\u5e2d\u6267\u884c\u5b98Silviu Itescu\u535a\u58eb\u8bf4\u3002 FDA\u8bbe\u5b9a\u4e86\u201c\u5904\u65b9\u836f\u4f7f\u7528\u8d39\u6cd5\u6848(PDUFA)\u201d\u7684\u884c\u52a8\u65e5\u671f\u4e3a2020\u5e749\u670830\u65e5\uff0c\u5982\u679c\u83b7\u5f97\u6279\u51c6\uff0cMesoblast\u5c06\u7acb\u5373\u5728\u7f8e\u56fd\u53d1\u5e03Ryoncil\u3002 \u5728\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u60a3\u8005\u7684\u8fc7\u7a0b\u4e2d\uff0c\u6f5c\u5728\u7684Ryoncil\u7684\u4f7f\u7528\u4e5f\u53ef\u80fd\u8fdb\u4e00\u6b65\u4fc3\u8fdb\u624b\u672f\u7684\u8fdb\u5c55\u3002 \u76ee\u524d\uff0c\u8be5\u836f\u6b63\u5728\u7f8e\u56fd\u8fdb\u884c3\u671f\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\uff0c\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u5728\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u60a3\u8005\u4e2d\uff0c\u6709\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u7684\u60a3\u8005\u4f7f\u7528\u7684\u662fremestemcel-L\u3002 Mesoblast\u62a5\u9053\uff0c\u5f53\u5176\u836f\u7269\u88ab\u7ed9\u4e8812\u540d\u4f53\u6064\u4f7f\u7528\u7684\u60a3\u8005\u65f6\uff0c75%\u7684\u547c\u5438\u673a\u4f9d\u8d56\u60a3\u8005\u572810\u5929\u5185\u5373\u53ef\u8131\u79bb\u547c\u5438\u673a\u51fa\u9662\u3002 \u5728\u8fc7\u53bb\u76849\u4e2a\u6708\u91cc\uff0cMesoblast\u57fa\u4e8eSR-aGVHD\u4e2dremestemcel-L\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u6570\u636e\uff0c\u63d0\u4ea4\u4e86\u4e00\u4efd\u4f7f\u7528remestemcel-L\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u5f15\u8d77\u7684ARDS\u7684\u8bd5\u9a8c\u6027\u65b0\u836f(IND)\u7533\u8bf7\uff0c\u5e76\u83b7\u5f97FDA\u6279\u51c6\u3002 \u8be5\u516c\u53f8\u8868\u793a\uff0c\u76ee\u524d\uff0c\u4e00\u9879\u9488\u5bf9\u7f8e\u56fd30\u4e2a\u5730\u533a\u7684300\u540d\u51a0\u72b6\u75c5\u6bd2\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u60a3\u8005\u76843\u671f\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\u6b63\u5728\u8fdb\u884c\u4e2d\uff0c\u201c\u8ba1\u5212\u4e2d\u7684\u4e2d\u671f\u5206\u6790\u53ef\u80fd\u4f1a\u5bfc\u81f4\u8bd5\u9a8c\u56e0\u6709\u6548\u6027\u6216\u65e0\u6548\u800c\u63d0\u524d\u7ec8\u6b62\u201d\u3002 \u91cc\u7a0b\u7891\u76ee\u6807 \u5728\u5c55\u671b\u672a\u676512\u4e2a\u6708\u7684\u76ee\u6807\u65b9\u9762\uff0cMesoblast\u8868\u793a\uff0c\u5c3d\u7ba1\u51a0\u72b6\u75c5\u6bd2\u75c5\u5bf9\u5168\u7403\u7ecf\u6d4e\u7684\u5404\u4e2a\u9886\u57df\u90fd\u9020\u6210\u4e86\u5f71\u54cd\uff0c\u4f46\u5b83\u6253\u7b97\u57282020\u5e74\u5e95\u4e4b\u524d\u5728\u7f8e\u56fd\u63a8\u51faRyoncil\u3002 \u5176\u4ed6\u91cc\u7a0b\u7891\u76ee\u6807\u5305\u62ec\u5b8c\u6210Ryoncil\u6cbb\u7597ARDS\u548cRevascor\u6cbb\u7597\u665a\u671f\u548c\u665a\u671f\u5fc3\u529b\u8870\u7aed\u76843\u671f\u8bd5\u9a8c\u3002 \u6b64\u5916\uff0c\u53e6\u4e00\u9879\u9488\u5bf9\u9000\u53d8\u6027\u690e\u95f4\u76d8\u75be\u75c5\u5f15\u8d77\u7684\u6162\u6027\u4e0b\u8170\u75db\u7684MPC-06-ID\u76843\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6b63\u5728\u8fdb\u884c\u4e2d\u3002 Mesoblast\u8868\u793a\uff0c\u6240\u6709\u60a3\u8005\u7684\u6700\u7ec8\u7814\u7a76\u8bbf\u95ee\u5df2\u7ecf\u5b8c\u6210\uff0c\u6240\u6709\u6570\u636e\u7684\u6301\u7eed\u8d28\u91cf\u5ba1\u67e5\u4e5f\u6b63\u5728\u76f8\u5173\u7814\u7a76\u5730\u70b9\u5b8c\u6210\uff0c\u201c\u6570\u636e\u8bfb\u51fa\u8ba1\u5212\u57282020\u5e74\u4e2d\u671f\u201d\uff0c\u8be5\u516c\u53f8\u8868\u793a\u3002 \u672c\u5468\u65e9\u4e9b\u65f6\u5019,Mesoblast\u544a\u8bc9\u5e02\u573a,\u4e34\u5e8a\u7ed3\u679c\u7684\u540c\u79cd\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSC)\u533b\u5b66\u5728\u513f\u7ae5\u548c\u6210\u4eba\u5728\u4e09\u4e2a\u540c\u884c\u8bc4\u8bae\u7684\u6587\u7ae0\u548c\u793e\u8bba\u53d1\u8868\u5728\u751f\u7269\u5b66\u7684\u53ef\u80fd\u95ee\u9898\u7684\u8840\u6db2\u548c\u9aa8\u9ad3\u79fb\u690d,\u7f8e\u56fd\u79fb\u690d\u5b66\u4f1a\u7684\u5b98\u65b9\u51fa\u7248\u7269\u548c\u7ec6\u80de\u7597\u6cd5\u3002 \u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0cMesoblast\u80a1\u4ef7\u4e0a\u6da8\u8fd14%\uff0c\u81f33.98\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":5,"featured_media":8010,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[95],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil<\/title>\n<meta name=\"description\" content=\"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil\" \/>\n<meta property=\"og:description\" content=\"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-28T01:09:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Mesoblast-ASX-MSB-revenues-remestemcel-L-Ryoncil-GvHD.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil\" \/>\n<meta name=\"twitter:description\" content=\"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Mesoblast-ASX-MSB-revenues-remestemcel-L-Ryoncil-GvHD.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/\",\"name\":\"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-28T01:09:30+00:00\",\"dateModified\":\"2023-08-29T18:02:04+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil","description":"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil","og_description":"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-28T01:09:30+00:00","article_modified_time":"2023-08-29T18:02:04+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Mesoblast-ASX-MSB-revenues-remestemcel-L-Ryoncil-GvHD.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil","twitter_description":"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Mesoblast-ASX-MSB-revenues-remestemcel-L-Ryoncil-GvHD.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/","url":"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/","name":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-28T01:09:30+00:00","dateModified":"2023-08-29T18:02:04+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u5728\u4e00\u4efd\u5173\u6ce8\u8fc7\u53bb9\u4e2a\u6708\u7684\u4e2d\u671f\u4e1a\u7ee9\u66f4\u65b0\u4e2d\uff0c\u53cc\u91cd\u4e0a\u5e02\u7684\u7ec6\u80de\u836f\u7269\u516c\u53f8Mesoblast (ASX: MSB)\u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5b9e\u73b0\u4e86\u201c\u5f3a\u52b2\u7684\u8d22\u52a1\u72b6\u51b5\u201d\uff0c\u5e76\u5728\u5176\u5148\u5bfc\u836f\u7269remestemcel-L\u65b9\u9762\u53d6\u5f97\u4e86\u8fdb\u5c55\u3002\u8fd9\u79cd\u836f\u7269\u6b63\u5728\u5f00\u53d1\uff0c\u7528\u4e8e\u6cbb\u7597\u4e25\u91cd\u7684\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-strong-revenue-growth-busy-clinical-program-upcoming-ryoncil-launch\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Mesoblast\u770b\u5230\u4e86\u5f3a\u52b2\u7684\u6536\u5165\u589e\u957f\uff0c\u4fdd\u6301\u7e41\u5fd9\u7684\u4e34\u5e8a\u9879\u76ee\u5e76\u5373\u5c06\u63a8\u51fa\u7684Ryoncil"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1252"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1252"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1252\/revisions"}],"predecessor-version":[{"id":8009,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1252\/revisions\/8009"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8010"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}